India's cheap weight-loss drugs could reshape global obesity fight
#India #weight-loss drugs #obesity #generic medicines #semaglutide #pharmaceutical market #affordable healthcare
📌 Key Takeaways
- India is producing low-cost versions of weight-loss drugs like semaglutide.
- These affordable alternatives could expand access to obesity treatments globally.
- The move may disrupt the pharmaceutical market dominated by Western companies.
- It highlights India's role as a major supplier of generic medicines.
📖 Full Retelling
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
🏷️ Themes
Healthcare, Pharmaceuticals
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Read full article at source